Ligand-activated Flpe for temporally regulated gene modifications
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The selectivity by which site-specific recombinase-mediated genetic changes can be targeted to specific cells in the mouse has been limited by the fact that many genes used as recombinase "drivers" are expressed either in cell populations that change over time or constitutively in a given cell population for an extended time period, for example, in a germinal zone that gives rise successively to different lineages. These scenarios limit the selective dimension of conditional gene modification experiments as they preclude studying the later-generated lineages either because of earlier phenotypes (in the case of conditional mutagenesis experiments) or because the early and permanent activation of a reporter in a germinal zone results in all descendant lineages being marked (in the case of fate-mapping experiments). To circumvent this limitation, inducible forms of Cre recombinase have been developed, enabling the induction of genetic changes in late embryonic or adult cells accessible only through late aspects of a dynamic driver gene expression profile. To increase the number of tools available for engineering genetic changes in selective cell populations, we have generated a ligand-regulated form of Flpe using the recombinase-steroid receptor fusion approach. In two prototypical scenarios, we show that the fused gene product, FlpeER(T2), is competent to mediate DNA recombination in vivo and responds specifically to the inducer tamoxifen in a dose-dependent manner without detectable background activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ligand-activated site-specific recombination in mice.
Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., & Chambon, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10887 · Cited by 907
Chung, J. H., Whiteley, M., & Felsenfeld, G. (1993) · Cell · doi:10.1016/0092-8674(93)80052-g · Cited by 854
Reduced levels of hsp90 compromise steroid receptor action in vivo
Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G., Lindquist, S., & Yamamoto, K. R. (1990) · Nature · doi:10.1038/348166a0 · Cited by 787 · cited 1×
“…of the ERT2 domain to sequester the FlpeERT2 fusion protein into a cytoplasmic Hsp90 complex in the absence of 4-OHT (Bohen and Yamamoto, 1993; Picard et al., 1990; Scherrer et al., 1993), but release the fusion protein in the presence of 4-OHT, freeing it to enter the nucleus and mediate…”
BackgroundMetzger, D., Clifford, J., Chiba, H., & Chambon, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6991 · Cited by 570 · cited 1×
“…recombinase; tamoxifen Ligand-regulated forms of the site-specific DNA recombinase Cre have been developed with the goal of adding temporal control to recombinase activity (Feil et al., 1996, 1997; Indra et al., 1999; Kellendonk et al., 1996; Logie and Stewart, 1995; Metzger et al., 1995).”
BackgroundCryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation
Awatramani, R., Soriano, P., Rodriguez, C., Mai, J. J., & Dymecki, S. M. (2003) · Nature Genetics · doi:10.1038/ng1228 · Cited by 215
Self-citationIsolation of Hsp90 mutants by screening for decreased steroid receptor function.
Bohen, S. P., & Yamamoto, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11424 · Cited by 195
Cited by
Controlled expression of transgenes introduced by in vivo electroporation
Matsuda, T., & Cepko, C. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610155104 · Cited by 663
Early patterning and specification of cardiac progenitors in gastrulating mesoderm
Devine, W. P., Wythe, J. D., George, M., Koshiba-Takeuchi, K., & Bruneau, B. G. (2014) · eLife · doi:10.7554/elife.03848 · Cited by 253
Genetic Approaches to Neural Circuits in the Mouse
Josh Huang, Z., & Zeng, H. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062012-170307 · Cited by 200
Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools
Joksimovic, M., Anderegg, A., Roy, A., Campochiaro, L., Yun, B., Kittappa, R., McKay, R., & Awatramani, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904285106 · Cited by 121
Self-citationGenetic dissection of GABAergic neural circuits in mouse neocortex
Taniguchi, H. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00008 · Cited by 106
“Second, Arch Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 8 | 9 “fncel-08-00008” — 2014/1/23 — 16:36 — page 10 — #10 is a proton pump activated by green light, which can drive large inhibitory currents (Idnurm and Howlett, 2001; Chow et al., 2010).”
BackgroundSite-Specific Recombinases for Manipulation of the Mouse Genome
Birling, M.-C., Gofflot, F., & Warot, X. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-019-9_16 · Cited by 106
Essentials of Recombinase-Based Genetic Fate Mapping in Mice
Jensen, P., & Dymecki, S. M. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-60327-292-6_26 · Cited by 54
Self-citationIntersectional mapping of multi-transmitter neurons and other cell types in the brain
Xu, J., Jo, A., DeVries, R. P., Deniz, S., Cherian, S., Sunmola, I., Song, X., Marshall, J. J., Gruner, K. A., Daigle, T. L., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111036 · Cited by 27
“In the future, replacing Cre and Flp drivers with Cre-ER (Feil et al., 1996; Metzger et al., 1995) and Flp-ER (Hunter et al., 2005) drivers would allow one to trace the expression of glutamate and GABA at each developmental stage and target specific time periods to investigate the functional…”
Metadata
- Authors
- Hunter, N. L., Awatramani, R. B., Farley, F. W., & Dymecki, S. M.
- Venue
- genesis
- Publisher
- Wiley
- Published
- 2005
- Volume
- 41
- Issue
- 3
- Pages
- 99-109
- ISSN
- 1526-954X (ISSN-L)
- 1526-968X
- OpenAlex
- W2048481957
- Cited by
- 59
- References
- 6
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.